The Institute for Biosystems and Bioengineering (IBB) is a hub for education and research centers in bioengineering and other relevant interdisciplinary research. This institute includes Research Center for Biomedical Engineering (RCBE), Research Center for Biomass Valorization (RCBV), Advanced Bioindustrial Engineering Lab (ABEL), and Biological Systems Engineering Lab (BSEL). The institute is dedicated to respond to the challenges in important areas of food production, infectious diseases, pollution, and environmental problems in our societies.
The Advanced Bioindustrial Engineering Laboratory (ABEL), integrated with the Pertamina-Biofuel Laboratory, is a dynamic research hub committed to advancing sustainable energy solutions through the conversion of biomass into clean fuels and valuable biochemicals.
Designed as a center for innovation in biorefinery, ABEL explores a wide range of renewable feedstocks—such as agricultural residues, lignocellulosic biomass, and microalgae—to produce next-generation biofuels like bioethanol, biodiesel, biobutanol, and biojet fuel. Beyond fuels, the lab focuses on extracting high-value products including organic acids, furan derivatives, bioplastics, and specialty chemicals, supporting a zero-waste, circular bioeconomy.
By combining cutting-edge research in biotechnology, catalysis, and process engineering with real-world industrial collaboration, ABEL serves as a vital link between academic discovery and commercial application, helping to drive Indonesia’s transition toward a greener, more resilient energy future.
The Biological Systems Engineering Lab (BSEL) is a research laboratory dedicated to the modeling of biological system interactions. It is equipped with advanced hardware, including servers, workstations, and state-of-the-art biomedical equipment, as well as continuously updated software. This facility supports research in biological system modeling, bioinformatics, and genetic engineering. Researchers at BSEL are engaged in efforts to discover treatments for various emerging diseases and to enhance the efficiency of biocatalysts for green synthesis applications.
